Article: Venetoclax-rituximab induces deep responses in relapsed CLL

Related products

• 

  Article: Calendar of events

  €2.42 Add to cart
• 

  Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma

  €2.42 Add to cart
• 

  Article: INTRODUCTION

  €2.42 Add to cart
• 

  Article: Highlights in melanoma

  €2.42 Add to cart